Avirup Guha: How Should Oncology Trials Define CV Safety Events?
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared a post on LinkedIn: “How should oncology trials define CV safety events? Marc Bonaca explains how Table 1 and Figure 1 from…
Read the full articleYou might also wanna read
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
Conditions : Breast Cancer Interventions : Other: Breast-conserving surgery, postoperative radiotherapy and individualized adjuvant systemic
O evento que integra ciência, liderança feminina e equidade na oncologia chega a São Paulo
Encontro debate o tratamento de casos complexos de câncer de mama e estratégias para fortalecer o protagonismo das mulheres na medicina
What ASCO 2026 Taught Us About Scaling AI in Cancer Care
By Arturo Loaiza-Bonilla, MD, MSEd A woman completes human papillomavirus (HPV) self-collection in a community clinic, receives an abnormal
EMA advisor discusses real-world data and single-arm trials in oncology drug approvals
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in th
omny.fm·11d ago
Oncoclínicas: a estratégia dos minoritários na ‘novela’ societária
Matéria exclusiva para assinantes. Para ter acesso completo, acesse o link da matéria e faça o seu cadastro.
Comments
Sign in to join the conversation.
No comments yet. Be the first.